Nationwide Fund Advisors’s ENZON PHARMACEUTICALS INC ENZN Stock Holding History

Nationwide Fund Advisors’s Portfolio ENZN Stock Details ENZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-130,278	Closed	-$126K	–	3304
2015 Q3	$126K	Hold	130,278	–	–	﹤0.01%	2810
2015 Q2	$156K	Sell	130,278 -91,500	-41%	-$117K	﹤0.01%	2843
2015 Q1	$235K	Hold	221,778	–	–	﹤0.01%	2611
2014 Q4	$242K	Sell	221,778 -59,343	-21%	-$62.3K	﹤0.01%	2532
2014 Q3	$304K	Buy	281,121 +278,219	+9,587%	+$343K	﹤0.01%	2494
2014 Q2	$3K	Sell	2,902 -28,682	-91%	-$27.3K	﹤0.01%	3291
2014 Q1	$33K	Hold	31,584	–	–	﹤0.01%	2883
2013 Q4	$37K	Sell	31,584 -2,084	-6%	-$3.21K	﹤0.01%	3084
2013 Q3	$57K	Buy	33,668 +2,035	+6%	+$3.77K	﹤0.01%	3037
2013 Q2	$63K	Buy	+31,633	New	+$92.6K	﹤0.01%	2918

Other funds holding ENZN

Icahn Carl Sunny Isles Beach, Florida $8.55B AUM 29.29% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return

Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $43.4B AUM 51.29% 1-Year Est. Return

Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return

SCP

Seizert Capital Partners Birmingham, Michigan $2.17B AUM 11.2% 1-Year Est. Return

California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return

Nationwide Fund Advisors's ENZN Position: Q4 2015 in Review

Nationwide Fund Advisors sold out of ENZON PHARMACEUTICALS INC (ENZN) in Q4 2015, closing a stake of 130,278 shares — an estimated $126K sold.

Nationwide Fund Advisors first reported a position in ENZN in Q2 2013 and held it in 10 quarters. The position peaked at $304K in Q3 2014. 49 funds tracked by Wall St. Rank hold ENZN as of Q4 2015.

Nationwide Fund Advisors reported no remaining ENZON PHARMACEUTICALS INC position as of Q4 2015 after selling out during the quarter.
Nationwide Fund Advisors sold 130,278 ENZON PHARMACEUTICALS INC shares in Q4 2015, an estimated $126K.
Nationwide Fund Advisors first reported a position in ENZON PHARMACEUTICALS INC in Q2 2013 and held it in 10 quarters.
Nationwide Fund Advisors's ENZON PHARMACEUTICALS INC position peaked at $304K in Q3 2014.
49 funds tracked by Wall St. Rank held ENZON PHARMACEUTICALS INC as of Q4 2015.

Based on Nationwide Fund Advisors's 13F filing for Q4 2015, filed 29 Jan 2016.